Your browser doesn't support javascript.
loading
The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor.
Brandão, Andreia; Paulo, Paula; Maia, Sofia; Pinheiro, Manuela; Peixoto, Ana; Cardoso, Marta; Silva, Maria P; Santos, Catarina; Eeles, Rosalind A; Kote-Jarai, Zsofia; Muir, Kenneth; Schleutker, Johanna; Wang, Ying; Pashayan, Nora; Batra, Jyotsna; Grönberg, Henrik; Neal, David E; Nordestgaard, Børge G; Tangen, Catherine M; Southey, Melissa C; Wolk, Alicja; Albanes, Demetrius; Haiman, Christopher A; Travis, Ruth C; Stanford, Janet L; Mucci, Lorelei A; West, Catharine M L; Nielsen, Sune F; Kibel, Adam S; Cussenot, Olivier; Berndt, Sonja I; Koutros, Stella; Sørensen, Karina Dalsgaard; Cybulski, Cezary; Grindedal, Eli Marie; Park, Jong Y; Ingles, Sue A; Maier, Christiane; Hamilton, Robert J; Rosenstein, Barry S; Vega, Ana; Kogevinas, Manolis; Wiklund, Fredrik; Penney, Kathryn L; Brenner, Hermann; John, Esther M; Kaneva, Radka; Logothetis, Christopher J; Neuhausen, Susan L; Ruyck, Kim De.
Afiliação
  • Brandão A; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
  • Paulo P; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
  • Maia S; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
  • Pinheiro M; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
  • Peixoto A; Department of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
  • Cardoso M; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
  • Silva MP; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
  • Santos C; Department of Genetics, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
  • Eeles RA; The Institute of Cancer Research, London SM2 5NG, UK.
  • Kote-Jarai Z; Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.
  • Muir K; The Institute of Cancer Research, London SM2 5NG, UK.
  • Ukgpcs Collaborators; Division of Population Health, Health Services Research and Primary Care, University of Manchester, Oxford Road, Manchester M13 9PL, UK.
  • Schleutker J; Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.
  • Wang Y; The Institute of Cancer Research, London SW7 3RP, UK.
  • Pashayan N; Institute of Biomedicine, University of Turku, FI-20014 Turun Yliopisto, 20050 Turku, Finland.
  • Batra J; Department of Medical Genetics, Genomics, Laboratory Division, Turku University Hospital, P.O. Box 52, 20521 Turku, Finland.
  • Apcb BioResource; Department of Population Science, American Cancer Society, 250 Williams Street, Atlanta, GA 30303, USA.
  • Grönberg H; Department of Applied Health Research, University College London, London WC1E 7HB, UK.
  • Neal DE; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK.
  • Nordestgaard BG; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD 4059, Australia.
  • Tangen CM; Translational Research Institute, Brisbane, QLD 4102, Australia.
  • Southey MC; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD 4059, Australia.
  • Wolk A; Translational Research Institute, Brisbane, QLD 4102, Australia.
  • Albanes D; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, SE-171 77 Stockholm, Sweden.
  • Haiman CA; Nuffield Department of Surgical Sciences, University of Oxford, Room 6603, Level 6, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK.
  • Travis RC; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.
  • Stanford JL; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge CB2 0RE, UK.
  • Mucci LA; Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
  • West CML; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200 Copenhagen, Denmark.
  • Nielsen SF; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M3-C102, Seattle, WA 98109-1024, USA.
  • Kibel AS; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC 3168, Australia.
  • Cussenot O; Cancer Epidemiology Division, Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC 3004, Australia.
  • Berndt SI; Department of Clinical Pathology, The Melbourne Medical School, The University of Melbourne, Melbourne, VIC 3004, Australia.
  • Koutros S; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
  • Sørensen KD; Department of Surgical Sciences, Uppsala University, 75185 Uppsala, Sweden.
  • Cybulski C; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, ML 20892, USA.
  • Grindedal EM; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA 90015, USA.
  • Park JY; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, UK.
  • Ingles SA; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, DC 98109-1024, USA.
  • Maier C; Department of Epidemiology, School of Public Health, University of Washington, Seattle, DC 98195, USA.
  • Hamilton RJ; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.
  • Rosenstein BS; Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Radiotherapy Related Research, The Christie Hospital NHS Foundation Trust, Manchester M13 9PL, UK.
  • Vega A; Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
  • The Impact Study Steering Committee And Collaborators; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200 Copenhagen, Denmark.
  • Kogevinas M; Division of Urologic Surgery, Brigham and Womens Hospital, 75 Francis Street, Boston, MA 02115, USA.
  • Wiklund F; Sorbonne Universite, GRC n 5, AP-HP, Tenon Hospital, 4 rue de la Chine, F-75020 Paris, France.
  • Penney KL; CeRePP, Tenon Hospital, F-75020 Paris, France.
  • Brenner H; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, ML 20892, USA.
  • John EM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, ML 20892, USA.
  • Kaneva R; Department of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensen Boulevard 99, 8200 Aarhus N, Denmark.
Cancers (Basel) ; 12(11)2020 Nov 04.
Article em En | MEDLINE | ID: mdl-33158149

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article